High-Density Lipoprotein — The Clinical Implications of Recent Studies

New England Journal of Medicine

Volumn 321, Issue 19, 1989, Pages 1311-1316

  Desforges, Jane F ^a   Gordon, David J ^b   Rifkind, Basil M ^b  

^a Lung and Blood Institute ^*

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN;

HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

CORONARY DISEASE; HUMAN; LIPOPROTEINS, HDL; LIPOPROTEINS, HDL CHOLESTEROL;

EID: 0024449985     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198911093211907     Document Type: Review

References (52)

1. Gofman JW, Lindgren F, Elliott H, et al. The role of lipids and lipoproteins in atherosclerosis. Science 1950; 111: 166–71.
2. Gofman JW, deLalla O, Glazier F, et al. The serum lipid transport system in health, metabolic disorders, atherosclerosis, and coronary artery disease. Plasma 1954; 2: 413–84.
3. Barr DP, Russ EM, Eder HA. Protein-lipid relationship in human plasma. II. In atherosclerosis and related conditions. Am J Med 1951; 11: 480–93.
4. Miller GJ, Miller NE. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet 1975; 1: 16–9.
5. Rhoads GG, Gulbrandsen CL, Kagan A. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. N Engl J Med 1976; 294: 293–8.
6. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High-density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med 1977; 62: 707–14.
7. Miller NE, Thelle DS, Førde OH, Mjøs OD. The Tromsø heart-study: high-density lipoprotein and coronary heart-disease: a prospective case–control study. Lancet 1977; 1: 965–8.
8. Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987; 317: 1237–45.
9. Manninen V, Elo MO, Frick MH, et al. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart study. JAMA 1988; 260: 641–51.
10. Eisenberg S. High density lipoprotein metabolism. J Lipid Res 1984; 25: 1017–58.
11. Anderson DW, Nichols AV, Pan SS, Lindgren FT. High density lipoprotein distribution: resolution and determination of three major components in a normal population sample. Atherosclerosis 1978; 29: 161–79.
12. Glomset JA. The plasma lecithins: cholesterol acyltransferase reaction. J Lipid Res 1968; 9: 155–67.
13. Heiss G, Johnson NJ, Reiland S, Davis CE, Tyroler HA. The epidemiology of plasma high-density lipoprotein cholesterol levels: the Lipid Research Clinics Program Prevalence Study: summary. Circulation 1980; 62: Suppl IV: IV-116–IV-136.
14. Godsland IF, Wynn V, Crook D, Miller NE. Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. Am Heart J 1987; 114: 1467–503.
15. Tyroler HA, Glueck CJ, Christensen B, Kwiterovich PO Jr. Plasma high-density lipoprotein cholesterol comparisons in black and white populations: the Lipid Research Clinics Program Prevalence Study. Circulation 1980; 62: Suppl IV: IV-99–IV-107.
16. Hulley SB, Cohen R, Widdowson G. Plasma high-density lipoprotein cholesterol level: influence of risk factor intervention. JAMA 1977; 238: 2269–71.
17. Anderson KM, Wilson PW, Garrison RJ, Castelli WP. Longitudinal and secular trends in lipoprotein cholesterol measurements in a general population sample: the Framingham Offspring Study. Atherosclerosis 1987; 68: 59–66.
18. Ernst N, Fisher M, Smith W, et al. The association of plasma high-density lipoprotein cholesterol with dietary intake and alcohol consumption: the Lipid Research Clinics Program Prevalence Study. Circulation 1980; 62: Suppl IV: IV-41–IV-52.
19. Dwyer T, Calvert GD, Baghurst KI, Leitch DR. Diet, other lifestyle factors and HDL cholesterol in a population of Australian male service recruits. Am J Epidemiol 1981; 114: 683–96.
20. Sacks FM, Ornish D, Rosner B, McLanahan S, Castelli WP, Kass EH. Plasma lipoprotein levels in vegetarians: the effects of ingestion of fats from dairy products. JAMA 1985; 254: 1337–41.
21. Thorogood M, Carter R, Benfield R, McPherson K, Mann JI. Plasma lipids and lipoprotein cholesterol concentrations in people with different diets in Britain. Br Med J 1987; 295: 351–3.
22. Amtzenius achéal, Kromhout D, Barth JD, et al. Diet, lipoproteins, and the progression of coronary atherosclerosis: the Leiden Intervention Trial. N Engl J Med 1985; 312: 805–11.
23. Knuiman JT, West CE, Katan MB, Hautvast JG. Total cholesterol and high density lipoprotein cholesterol levels in populations differing in fat and carbohydrate intake. Arteriosclerosis 1987; 7: 612–9.
24. Mattson FH, Grundy SM. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res 1985; 26: 194–202.
25. Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987; 28: 613–28.
26. Robinson D, Ferns GA, Bevan EA, Stocks J, Williams PT, Galton DJ. High density lipoprotein subfractions and coronary risk factors in normal men. Arteriosclerosis 1987; 7: 341–6.
27. Miller NE. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J 1987; 113: 589–97.
28. Davis CE, Gordon D, LaRosa J, Wood PDS, Halperin M. Correlations of plasma high-density lipoprotein cholesterol levels with other plasma lipid and lipoprotein concentrations: the Lipids Research Clinics Program Prevalence Study. Circulation 1980; 62: Suppl IV: IV-24–IV-30.
29. Schaefer EJ. Clinical, biochemical, and genetic features in familial disorders of high density lipoprotein deficiency. Arteriosclerosis 1984; 4: 303–22.
30. Humphries SE. DNA polymorphisms of the apolipoprotein genes — their use in the investigation of the genetic component of hyperlipidaemia and atherosclerosis. Atherosclerosis 1988; 72: 89–108.
31. Glueck CJ, Gartside PS, Steiner PM, et al. Hyperalpha- and hypobetalipoproteinemia in octogenarian kindreds. Atherosclerosis 1977; 27: 387–406.
32. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 1989; 79: 8–15.
33. Keys A. Alpha lipoprotein (HDL) cholesterol in the serum and the risk of coronary heart disease and death. Lancet 1980; 2: 603–6.
34. Gordon DJ, Knoke J, Probstfield JL, Superko R, Tyroler HA. High density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention trial. Circulation 1986; 74: 1217–25.
35. Watkins LO, Neaton JD, Kuller LH. Racial differences in high-density lipoprotein cholesterol and coronary heart disease incidence in the usual-care group of the Multiple Risk Factor Intervention trial. Am J Cardiol 1986; 57: 538–45.
36. Pocock SJ, Shaper AG, Phillips AN, Walker M, Whitehead TP. High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men. Br Med J 1986; 292: 515–9.
37. Enger SC, Hjermann I, Foss OP, et al. High-density lipoprotein cholesterol and myocardial infarction and sudden coronary death: a prospective case–control study in middle-aged men of the Oslo study. Artery 1979; 5: 170–81.
38. Wiklund O, Wilhelmsen L, Elmfeldt D, Wedel H, Valek J, Gustafson A. Alpha-lipoprotein cholesterol concentration in relation to subsequent myocardial infarction in hypercholesterolemic men. Atherosclerosis 1980; 37: 47–53.
39. Keys A, Karvonen MJ, Punsar S, Menotti A, Fidanza F, Farchi G. HDL serum cholesterol and 24-year mortality of men in Finland. Int J Epidemiol 1984; 13: 428–35.
40. Assman G, Schulte H. PROCAM-TRIAL Prospective Cardiovascular Munster Trial. Hedigen/Zurich: Panscientia Verlag, 1986.
41. Levy RI, Klimov AN. High density lipoprotein cholesterol (HDL-C) and mortality in USSR and US middle age men: the Collaborative US-USSR Mortality Follow-Up Study. Circulation 1987; 76: Suppl IV: IV-167. abstract.
42. Goldbourt U, Holtzman E, Neufeld HN. Total and high density lipoprotein cholesterol in the serum and risk of mortality: evidence of the threshold effect. Br Med J 1985; 290: 1239–43.
43. Simons LA. Interrelations of lipids and lipoproteins with coronary artery disease mortality in 19 countries. Am J Cardiol 1986; 57: 5G–10G.
44. Superko HR. Bachorik PS, Wood PD. High-density lipoprotein cholesterol measurements: a help or hindrance in practical clinical medicine? JAMA 1986; 256: 2714–7.
45. Hunninghake D, Gordon DJ, Tamir I, Rifkind BM. Management of hyperlipidemia. In: Pradhan SN, Maickel RP, Dutta SN, eds. Textbook of pharmacology. Bethesda, Md.: SP Press International, 1986:617–33.
46. Canner PL, Berge KG, Wenger NK, et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 1986; 8: 1245–55.
47. Levy RI, Brenske JF, Epstein SE, et al. The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of the NHLBI Type II Coronary Intervention study. Circulation 1984; 69: 325–37.
48. Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987; 257: 3233–40.
49. Bush TL, Cowan LD, Barrett-Connor E, et al. Estrogen use and all-cause mortality: preliminary results from the Lipid Research Clinics Program Follow-up study. JAMA 1983; 249: 903–6.
50. Rifkind BM. Gemfibrozil, lipids, and coronary risk. N Engl J Med 1987; 317: 1279–81.
51. The Expert Panel. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med 1988; 148: 36–69.
52. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD. Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA 1986; 256: 2835–8.